AKR1B10
MOLECULAR TARGETaldo-keto reductase family 1 member B10
AKR1B10 (aldo-keto reductase family 1 member B10) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AKR1B10
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Oleanolic Acid | 2.30 | 9 |
| 2 | Ursolic Acid | 2.08 | 7 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 1.39 | 3 |
| 4 | Chlorogenic Acid | 1.10 | 2 |
| 5 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.10 | 2 |
| 6 | caffeic acid | 0.69 | 1 |
| 7 | Pueraria | 0.69 | 1 |
| 8 | egcg | 0.69 | 1 |
| 9 | Kaempferols | 0.69 | 1 |
| 10 | Quercetin | 0.69 | 1 |
| 11 | Rutin | 0.69 | 1 |
| 12 | Hesperidin | 0.69 | 1 |
| 13 | phlorhizin | 0.69 | 1 |
| 14 | Sulindac | 0.69 | 1 |
| 15 | alphitonin [Supplementary Concept] from | 0.69 | 1 |
| 16 | Pennisetum | 0.69 | 1 |
About AKR1B10 as a Drug Target
AKR1B10 (aldo-keto reductase family 1 member B10) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented AKR1B10 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AKR1B10 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.